CITIUS ONCOLOGY INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.55
+4.63%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-43.5%
3 months
-11.4%
6 months
-41.4%
1 year
-68.0%
Year to date
-44.6%
52-week range
$0.49 – $1.75
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$51.5M
P/E
-1.1
P/B
1.3
P/S
7.2
Revenue
$7.11M
Net income
-$46.06M
Diluted EPS
-0.47
Gross margin
77.30%
Net margin
-648.30%
Return on equity
-103.00%
Total debt
$10.21M
Cash
$16.56M
Free cash flow
-$26.39M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $1.49M | -$8.92M | 67.10% | -597.40% | -$4.71M |
| Mar 31, 2026 | $1.67M | -$26.61M | 80.30% | -1596.00% | -$4.43M |
| Dec 31, 2025 | $3.94M | -$5.53M | 80.00% | -140.30% | -$11.75M |
| Sep 30, 2025 | $0 | -$5M | — | — | -$5.49M |
| Jun 30, 2025 | $0 | -$5.37M | — | — | $0 |
| Mar 31, 2025 | $0 | -$7.74M | — | — | $0 |
| Mar 31, 2025 | $0 | -$7.74M | — | — | $0 |
| Dec 31, 2024 | $0 | -$6.66M | — | — | $0 |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CTOR news
All market newsNo ticker-linked stories are in the current archive.